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https://doi.org/10.1016/j.stemcr.2017.12.005SUMMARYVarious mesenchymal cell types have been identified as critical components of the hematopoietic stem/progenitor cell (HSPC) niche.
Although several groups have described the generation of mesenchyme from human pluripotent stem cells (hPSCs), the capacity
of such cells to support hematopoiesis has not been reported. Here, we demonstrate that distinct mesenchymal subpopulations
co-emerge from mesoderm during hPSC differentiation. Despite co-expression of common mesenchymal markers (CD73, CD105,
CD90, and PDGFRb), a subset of cells defined as CD146hiCD73hi expressed genes associated with the HSPC niche and supported
the maintenance of functional HSPCs ex vivo, while CD146loCD73lo cells supported differentiation. Stromal support of HSPCs
was contact dependent and mediated in part through high JAG1 expression and low WNT signaling. Molecular profiling revealed
significant transcriptional similarity between hPSC-derived CD146++ and primary human CD146++ perivascular cells. The derivation
of functionally diverse types of mesenchyme from hPSCs opens potential avenues to model the HSPC niche and develop PSC-based
therapies.INTRODUCTION
Maintenance of bona fide self-renewing hematopoietic
stem and progenitor cells (HSPCs) ex vivo remains chal-
lenging in part because of our limited ability to recapitulate
the human HSPC niche in culture. Intensive research
efforts have begun to uncover the cellular and molecular
constituents of the niche that regulate self-renewal and
differentiation of HSPCs. Through the use of knockout
and transgenic mice, several cell populations have been
described in terms of their spatial relationship to the
bone and blood vessels of the bone marrow, and their
differential expression of various markers and bioactive
molecules (Ding et al., 2012; Itkin et al., 2016; Kobayashi
et al., 2010; Kunisaki et al., 2013).
High expression of melanoma-associated cell adhesion
molecule (CD146) identifies human pericytes, a cell type
that ensheaths capillaries, venules, arterioles, and sinu-
soids (Crisan et al., 2008) and can establish a heterotopic
hematopoietic stem cell (HSC) niche when transplanted
into immunodeficient mice (Sacchetti et al., 2007). Unlike
CD146 mesenchyme, monolayers of CD146++ cells
isolated from primary tissue (adult adipose tissue and fetal
bonemarrow) can support humanHSPCs co-cultured for at436 Stem Cell Reports j Vol. 10 j 436–446 j February 13, 2018 j ª 2017 The
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(Corselli et al., 2013).
We and others have shown that mesenchymal cells can
be differentiated from human pluripotent stem cells
(hPSCs) (Chin et al., 2016; Ferrell et al., 2014; Hoffman
and Calvi, 2014; Vodyanik et al., 2010). These previous
studies identified mesenchyme as a single population
defined mostly by expression of CD73 and/or CD105 and
absence of hematopoietic and endothelial markers. We
now report that the mesenchyme generated from hPSCs
is functionally and transcriptionally heterogeneous. Our
studies identified a distinct subpopulation of hPSC-derived
mesenchyme that expressed high levels of CD146 and
CD73 and low levels of PDGFRa (CD140a) and that
was capable of supporting clonogenic, engraftable, and
self-renewing human HSPCs ex vivo without exogenous
cytokines. In contrast CD146loCD73lo mesenchyme
showed significantly less capacity to support HSPCs. Tran-
scriptome analysis revealed that the CD146hiCD73hi cells
expressed significantly higher levels than CD146loCD73lo
cells of perivascular markers and niche factors known to
have critical roles in HSC maintenance. HSPC support
was dependent in part on cell-cell interactions and Notch
signaling through stromal expression of JAG1, whereasAuthor(s).
ecommons.org/licenses/by-nc-nd/4.0/).
differentiation was promoted by WNT signaling. Closer
transcriptional analysis, combining data from mesen-
chyme generated from hPSCs and human primary tissue,
revealed that dominant pathways shared by the CD146++
populations were those related to vascular development,
cell adhesion, and motility. Our data suggest that hPSC-
derived mesoderm can generate mesenchymal cells
phenotypically, functionally, and molecularly, similar to
previously identified primary pericytes that contribute to
the human HSPC niche.RESULTS
Heterogeneity of Embryonic Mesoderm-Derived
Mesenchymal Cells
We have previously characterized a human embryonic
mesoderm progenitor (hEMP) population derived from
hPSCs that marks the onset of mesoderm commitment
and has the potential to generate a broad range of
mesodermal derivatives, including mesenchyme, endo-
thelium, and bone, three lineages that play a crucial
role in the hematopoietic niche (Chin et al., 2016;
Hoffman and Calvi, 2014). hEMPs were isolated at day
3.5 of mesoderm differentiation from H1 embryonic
stem cells (Evseenko et al., 2010) (Figure 1A), and re-
cultured using conditions that favor mesenchymal differ-
entiation. After a further 14 days, cultures contained
a mixture of CD31+CD45 endothelial cells and
CD31CD45 mesenchymal cells. The mesenchymal
cells consisted of at least two populations that could be
discriminated based on expression of CD146, CD73,
and CD140a (PDGFRa) (Figure 1A). High co-expression
of CD146 and CD73 identified a largely CD140a popula-
tion, whereas CD146lo cells expressed intermediate levels
of CD73 and high levels of CD140a. This inverse expres-
sion pattern between CD146 and CD140a was consistent
with mesenchyme derived from primary human lipoaspi-
rates (Figure S1A). Despite the differential expression of
CD146, CD73, and CD140a, both hPSC-derived mesen-
chymal subsets expressed classic mesenchymal markers
CD90, CD105, CD44, and PDGFRb (Figure S1B).
Mesenchymal differentiation from two other hPSC lines,
UCLA3 and UCLA6, yielded similar populations to the
H1 line, with an inverse relationship of CD146 and
CD73 to CD140a expression (Figures S2A and S2B).
Although few CD146hiCD73hi cells were present early
in differentiation (days 4–5), the inverse expression
pattern of CD146 and CD73 to CD140a was present
throughout mesenchymal differentiation (Figure S2C).
To better understand whether the phenotypes above
identified distinct mesenchymal cell types, we focused
our studies on cells that represented the extremes ofthese phenotypes: a CD146hiCD73hi population and
a CD146loCD73lo population (Figure 1A). Bromode-
oxyuridine pulsing of hEMP-derived mesenchymal
cultures showed that a significantly higher frequency
of CD146hiCD73hi cells were cycling relative to
CD146loCD73lo cells (Figure 1B) (p % 0.05).
RNA sequencing (RNA-seq) profiling of the two
mesenchymal populations demonstrated that 916 genes
were differentially expressed (558 up- and 358 downre-
gulated in CD146hiCD73hi relative to CD146loCD73lo
cells; false discovery rate [FDR] < 0.01) (Figure 1C). Across
all hESC lines tested, CD146hiCD73hi mesenchyme
expressed significantly higher levels of pericyte markers
CSPG4 (which encodes NG2), NES (NESTIN), LEPR
(leptin receptor), and the b2-adrenergic receptor ADRB2
(Crisan et al., 2008; Hoffman and Calvi, 2014; Kunisaki
et al., 2013), and HSC regulatory genes, KITLG, IGFBP2,
and TNC (Ding et al., 2012; Huynh et al., 2008;
Nakamura-Ishizu et al., 2012; Zhang et al., 2008) (Figures
1C, S1C, S2A, and S2B). In contrast, the CD146loCD73lo
mesenchyme expressed significantly higher levels of
the niche factors CXCL12 and ADRB3 (Greenbaum
et al., 2013; Me´ndez-Ferrer et al., 2008) (Figure 1C).
Expression of extracellular matrix genes was upregulated
after the hEMP stage in both mesenchymal phenotypes
(Figure 1C).
Mesenchymal Support of HSPCs Ex Vivo
The ability of hEMP-derived CD146hiCD73hi and
CD146loCD73lo cells to support HSPCs ex vivo was assessed
by co-culturing cord blood (CB)-derived CD34+ cells on
monolayers generated from each mesenchymal popula-
tion. To determine the specific effect of each stromal sub-
set, cultures were performed in basal medium with a low
concentration of serum (5%) and without addition of
cytokines.
Although total hematopoietic (CD45+ cells) output was
similar with both mesenchymal populations (Figure 2A),
co-cultures with CD146hiCD73hi cells retained a signifi-
cantly higher frequency and number of total CD34+ cells
than co-culture with CD146loCD73lo mesenchymal cells
(Figures 2B and 2C) (p < 0.01 and p < 0.001, respectively,
n = 16). In particular, support of the more primitive
CD34+Lin subset was consistently seen in the
CD146hiCD73hi co-cultures (Figure 2D). Myeloid output
was higher in CD146hiCD73hi co-cultures, whereas more
B lymphoid cells were generated on CD146loCD73lo
mesenchyme (Figures 2E and 2F). Significantlymore clono-
genic cells (colony-forming unit [CFU]-C) weremaintained
in CD146hiCD73hi co-cultures than CD146loCD73lo co-
cultures (p < 0.001, n = 16; Figure 2G). Of note, multiple
other hPSC-derived phenotypic subsets were screened
based on their CD146 and CD140a expression; irrespectiveStem Cell Reports j Vol. 10 j 436–446 j February 13, 2018 437
Figure 1. Immunophenotypic Fractionation of hPSC-Derived Mesenchyme Reveals Transcriptionally Distinct Populations
(A) hEMPs were generated from hPSC and isolated at day 3.5 by FACS for further differentiation in mesenchymal conditions. After 2 weeks,
two distinct populations were identified within the CD31 (non-endothelial) cells, which were also CD45 (non-hematopoietic,
not shown). CD146loCD73lo cells (red) were CD140a+, and CD146hiCD73hi cells (blue) were CD140lo or CD140a (representative data using
H1 cells of n = 16 experiments).
(B) Cell-cycle analysis of hEMP-derived mesenchymal differentiation cultures at week 2, pulsed with bromodeoxyuridine (BrdU) for 40 min,
and gated on CD31 mesenchyme, as shown in Figure 1A, as either ‘‘CD146hiCD73hi’’ or ‘‘CD146loCD73lo.’’ n = 3 biological replicates.
The y axis shows the percentage of each mesenchymal phenotype in each stage of cell cycle, *p < 0.05, **p < 0.01, ***p < 0.001.
(C) Selected genes from RNA-seq profiling of hEMP, and hEMP-derived CD146hiCD73hi and CD146loCD73lo mesenchyme (as in Figure 1A).
Relative expression shown for each gene using its min/max moderate expression estimates as reference. n = 3 biological replicates.
Error bars represent SEM. See also Figures S1 and S2.of CD140a expression, those subsets with high levels of
CD146 best supported HSPCs (Figure S3A).
When LinCD34+ CD38 cells, a more primitive HSC-
enriched population were studied, the co-culture system
was modified by adding exogenous growth factors to
allow sufficient cell growth for analysis. In the presence
of cytokines, both mesenchymal populations were
able to support CD34+ cells for 2–4 weeks. However,
only the CD146hiCD73hi mesenchyme could maintain
CD34+CD38CD90+CD45RA, phenotypic long-term
HSCs (n = 4, p < 0.05), and CD34+CD33 cells (Figure S3B),
demonstrating again the functional differences between
the two mesenchymal populations in HSPC support.438 Stem Cell Reports j Vol. 10 j 436–446 j February 13, 2018CD146hiCD73hi Mesenchyme Maintains Human
HSPCs with Repopulating Ability and Self-Renewal
Potential
To understand whether support of engraftable HSPCs was
influenced by the different mesenchymal subsets, equal
numbers of CD34+ cells were co-cultured for 2 weeks with
CD146hiCD73hi or CD146loCD73lo cells, and then equal
numbers of total hematopoietic cells from the co-cultures
were transplanted into sublethally irradiated NOD/SCID/
IL-2 receptorg/ (NSG) mice. Of note, the co-culture con-
ditions were not designed to expand the number of CD34+
cells, as the cultures did not include growth factors
(in contrast to all current ex vivo expansion protocols).
Figure 2. CD146hiCD73hi Mesenchyme Supports Ex Vivo Maintenance of Clonogenic, Engraftable, and Self-Renewing HSPCs
CD146hiCD73hi and CD146loCD73lo mesenchymal cells generated from H1-derived hEMP were isolated and co-cultured as monolayers with
CB CD34+ cells in 5% serum without added cytokines. After 2 weeks, hematopoietic cells were assayed (A–G) in vitro and (H–J) in vivo.
(A) Total number of live (DAPI–) CD45+ cells recovered from co-cultures, shown as cell yield normalized to 1,000 input CD34+ cells.
(legend continued on next page)
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Based on flow cytometry analysis of bone marrow
(Figure 2H), a similar frequency of mice transplanted with
hematopoietic cells co-cultured with CD146hiCD73hi
cells engrafted (albeit at lower levels) compared with those
transplanted with fresh (non-cultured) CD34+ cells (11/12
versus 13/14, respectively) (Figures 2I and S3C), whereas
only 40% of mice transplanted with hematopoietic cells
fromCD146loCD73lo co-cultures demonstrated any detect-
able engraftment (R1% huCD45+HLA+ cells in bone
marrow) (p < 0.01) (Figure 2I). CD34+ progenitors and
multi-lineage reconstitution (CD19+ lymphoid cells and
CD14+ myeloid cells) were detected in the bone marrow,
spleen, and peripheral blood of all mice that received
hematopoietic cells from CD146hiCD73hi co-cultures (Fig-
ure 2H). Levels of engraftment were also significantly
higher in animals that receivedCD146hiCD73hi co-cultures
comparedwithCD146loCD73lo co-cultures (p < 0.001) (Fig-
ure 2J). Irrespective of stromal co-culture conditions, mice
that demonstrated primary engraftment could engraft in
secondary recipients (Figure 2J).
Together, these data indicate that at least two functionally
distinct mesenchymal populations were generated from
hPSC-derivedmesoderm;highCD146andCD73expression
markedamesenchymal subpopulationcapableofmaintain-
ing engraftableHSPCs ex vivo, whileCD146loCD73lomesen-
chyme had significantly less HSPC-supportive capacity.
HSPC Support Is Sustained through Intercellular
Interactions, in Part by Notch Signaling
Prevention of direct contact between CD146hiCD73hi
cells and CB CD34+ cells using a transwell culture system
significantly reduced the number of CD34+Lin cells
maintained in culture (p < 0.05, n = 3) (Figure 3A). Output
of CD146loCD73lo co-cultures was also reduced in
transwells, although to a lesser degree. Thus intercellular
mechanisms provide at least part of the HSPC-supportive
capacity of CD146hiCD73hi mesenchyme.
Notch signaling is a well-established cell contact-depen-
dent paracrine factor and deletion of Jagged1 (encoded by
Jag1) results in premature exhaustion of the murine HSC(B) Representative FACS analysis of CD45+ gated cells from co-culture
(C–G) Cell yield of CD34+, CD34+ Lin, CD14+ myeloid, CD10+/CD19+ B
CD146hiCD73hi co-cultures, normalized to CD146loCD73lo co-cultures.
(A and C–G) n = 16 independent experiments, each in duplicate. Show
two-tailed Student’s t test.
(H) Flow cytometry showing gating for the detection of human cells
transplant. PBS control with no cells injected.
(I) Proportion of mice with engraftment, i.e., detection of >1% human
either from fresh CB CD34+ cells (CB w/o culture), or 2 weeks after co
(J) Engraftment (percent of human cells) of mice 6 weeks after pri
total 9–14 mice per group; ***p <.0001; ns, not significant).
Error bars represent SEM. See also Figure S3.
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expressed the Notch ligand JAG1, with significantly higher
levels in CD146hiCD73hi mesenchyme (Figures 3B, S2A,
and S2B); DLL4 and DLL1 were not expressed in either
mesenchymal population (not shown). Expression of the
Notch target HES1 tended to be higher in the CD34+ cells
co-cultured with CD146hiCD73hi mesenchyme compared
with CD146loCD73lo supported hematopoietic cells
(p = 0.1789) (Figure 3C). Addition of a neutralizing anti-
body to human JAG1 caused a profound (>300-fold)
decrease in the number of CD34+Lin cells in
CD146hiCD73hi co-cultures (p % 0.05, n = 3) and
250-fold decrease in CD146loCD73lo co-cultures (Fig-
ure 3D). Of note, cell output was not significantly reduced
when anti-JAG1 was added to co-cultures on OP9, a mouse
stromal cell line, thus excluding non-specific cytotoxicity
from the blocking antibody (Figure S4A).
Thus, although expression of JAG1 was significantly
higher in CD146hiCD73hi stroma, HSPC support was
dependent on JAG1-mediated activation of Notch
signaling in both types of hPSC-mesenchymal co-cultures.
Wnt Inhibitors Are Highly Expressed in
CD146hiCD73hi Stroma
Across the entire RNA-seq dataset, the most highly differ-
entially expressed gene between CD146hiCD73hi and
CD146loCD73lo cells was the Wnt antagonist Secreted
Frizzled-Related Protein 1 (SFRP1) (33-fold difference,
FDR < 0.01) (Figure 3E). Expression of other Wnt inhibi-
tors was also significantly higher in CD146hiCD73hi
mesenchyme including SFRP2 (FDR < 0.001) and DKK1
(FDR < 0.001) (Figure 3E). Expression of Wnt downstream
targets TCF7 and LEF1 was significantly higher in hemato-
poietic cells supported by CD146loCD73lo co-cultures
compared with those by CD146hiCD73hi mesenchyme
(n = 5, p < 0.05) (Figure 3F).
Although neither addition of soluble SFRP1 or inhibition
of SFRP1 had any detectable effect on HSPCs in either
CD146hiCD73hi orCD146loCD73lo co-cultures (Figure S4B),
addition of a Wnt agonist, the GSK-3 inhibitor CHIR99021s.
lymphoid cells, and CFU (after re-plating) recovered from 2-week
n are mean ± SEM. *p < 0.05, **p < 0.01, ****p < 0.0001; unpaired
(hCD45+HLA ABC+) and multi-lineage reconstitution after primary
cells after primary transplant (1) with 13 105 CD45+ cells obtained
-culture on CD146hiCD73hi or CD146loCD73lo.
mary and secondary transplants (n = 5 independent experiments,
Figure 3. Notch Inhibition and Activation of Wnt Signaling in hPSC-Mesenchyme Co-cultures Leads to Loss of HSPC
(A) Shown is relative number of CD34+Lin cells in contact and transwell co-culture normalized to yield from CD146loCD73lo transwell
co-cultures (n = 3 independent experiments, mean ± SEM. *p < 0.05).
(B) qRT-PCR of JAG1 in CD146hiCD73hi and CD146loCD73lo mesenchyme (n = 14 biological replicates, **p < 0.01).
(C) qRT-PCR of HES1 in CD34+ cells recovered from CD146hiCD73hi and CD146loCD73lo mesenchyme after 7 days of co-culture without extra
cytokines (n = 5 biological replicates, p = 0.1789).
(D) Number of CD34+ Lin cells harvested from hPSC-mesenchyme after co-culture in the presence of human JAG1 blocking antibody or
control goat IgG (*p < 0.05, **p < 0.01, n = 3 independent experiments).
(E) Expression of WNT inhibitors SFRP1, SFRP2, and DKK1 in CD146hiCD73hi and CD146loCD73lo mesenchyme (n = 3 biological replicates,
RNA-seq **FDR < 0.01, ***FDR < 0.001).
(F) qRT-PCR of WNT target genes TCF7 and LEF1 in Lin+ cells recovered from CD146hiCD73hi and CD146loCD73lo mesenchyme after 7 days of
co-culture without extra cytokines (n = 5 biological replicates, *p < 0.05).
(G) CD34+ Lin, myeloid and lymphoid cell numbers after activation of Wnt signaling by addition of 3 mM CHIR99021 (*p < 0.05,
**p < 0.01, ***p < 0.001; ns, not significant; n = 3 independent experiments).
Error bars represent SEM. See also Figure S4.(CHIR), promoted rapid differentiation into both myeloid
and lymphoid lineages, and loss of CD34+Lin cells in
both CD146hiCD73hi and CD146loCD73lo co-cultures
(Figure 3G). This latter observation is consistent with
previous findings that canonical Wnt signaling regulates
hematopoiesis in a dosage-dependent fashion, with highWnt activation detrimental to HSC self-renewal leading to
depletion of the LT-HSC pool (Famili et al., 2016;
Luis et al., 2011). It is possible that functional redundancy
amongWnt inhibitors obscures the impact ofmanipulating
expression of single factors such as SFRP1 on HSPC support
during co-culture.Stem Cell Reports j Vol. 10 j 436–446 j February 13, 2018 441
hPSC-Derived CD146hiCD73hi Mesenchyme Shares a
Coordinated Gene Expression Profile that Resembles
that of Primary Human Pericytes
Given the complexity of signals produced in the HSC
niche, it seems likely that no single factor or mechanism
mediates the differential support of hematopoiesis from
different mesenchymal subpopulations. As molecular
characterization and functional studies of hPSC-derived
CD146hiCD73hi andCD146loCD73lomesenchyme showed
strong parallels to populations from primary human tissue,
we performed comparative transcriptome analysis of each
phenotypic population derived from hPSCs with those
from primary adipose tissue (freshly isolated or after
culture).
Principal-component analysis showed that the popula-
tions clustered mostly based on source rather than immu-
nophenotype (data not shown). Similar observations that
tissue-imprinted genes constitute major variances in unsu-
pervised analysis have been reported in other comparative
studies (Charbord et al., 2014). To uncover shared func-
tional gene sets across stromal lines with HSPC-supportive
capacity, we performed gene set enrichment analysis
(Subramanian et al., 2005) as follows. The most up- and
downregulated genes in hPSC-CD146hiCD73hi cells
(compared with hPSC-CD146loCD73lo cells) were defined
as positive and negative signatures, respectively (FDR < 0.01
and at least 2-fold difference). These signatures of hPSC-
derived CD146hiCD73hi cells were compared with the
global expression profiles of primary CD146+ pericytes,
ranked by differential expression to primary CD146 cells.
Significant enrichment was found between the positive
signatures of hPSC-derived CD146hiCD73hi cells with
genes upregulated in adult pericytes (Figure 4A, enrich-
ment score of 1.36 and 1.78 in fresh and cultured pericytes
respectively). Similarly, the negative signatures of hPSC-
CD146hiCD73hi cells were significantly enriched in genes
highly downregulated in primary pericytes (Figure 4B,
enrichment score of 1.77 and 1.39). Thus hPSC- and
adipose-derived CD146hiCD73hi cells exhibited similar
transcriptional signatures.
The shared core transcriptional signature obtained from
both hPSC- and adipose-derived CD146++ cells (104 genes,
Table S1) was imported into the STRING database to iden-
tify known and predicted protein interactions (STRING
protein-protein interaction enrichment p <10 3 1012)
(Figure 4C). Of note, the dominant functional categories
identified in the STRING analysis were those enriched in
biological processes characteristic of pericytes, i.e., cell
adhesion (FDR < 6 3 106), vasculature development
(FDR < 7 3 108), regulation of cell motion (FDR < 3 3
108), and wound healing (FDR < 33 104), among others
(Figure 4C). Therefore, the shared transcriptional signature
between hPSC- and adipose-derived CD146++ cells is442 Stem Cell Reports j Vol. 10 j 436–446 j February 13, 2018significantly enriched in processes involved in niche
homeostasis and maintenance.DISCUSSION
Mesenchymal stromal/stem cells, either derived from
primary tissues or differentiated from hPSC, are conven-
tionally isolated and expanded as a population of cells
loosely defined by CD73, CD105, and CD90 expression
(Murray et al., 2014). Our data strongly argue that
phenotypically, molecularly, and functionally distinct
populations coexist within these conventional definitions
of mesenchymal stroma. Previously, CD146 was shown to
define mesenchymal precursors adjacent to the vascula-
ture of multiple human organs, including bone marrow
and adipose tissues (Crisan et al., 2009). Other studies
have derived CD146+ pericytes from hPSCs, demon-
strating the capacity of these cells to reconstruct a vascular
network (Dar et al., 2012; Kusuma et al., 2013; Orlova et al.,
2014). Our previous work (Corselli et al., 2013) identified
immunophenotypic subsets of mesenchyme isolated
from human primary tissues and found that a subpopula-
tion of perivascular mesenchyme with high expression of
CD146 possessed significantly greater HSPC supporting
ability. In the current paper, we show that two pheno-
typically, functionally, and molecularly distinct mesen-
chymal populations can be faithfully recapitulated in the
hPSC system. We also provide the transcriptome profiling
of these mesenchymal populations, revealing the HSPC-
supportive CD146hiCD73hi cells to be closely related to
primary pericytes.
hPSC-derived CD146hiCD73hi mesenchyme showed
high expression of NES, LEPR, and CSPG4, markers of
peri-sinusoidal and peri-arteriolar cells in the murine
HSC niche (Ding et al., 2012; Kunisaki et al., 2013;
Me´ndez-Ferrer et al., 2010; Zhou et al., 2014). The
relevance of these perivascular cells has recently been
addressed in the context of human hematopoiesis
(Corselli et al., 2013; Pinho et al., 2013). PDGFRa/
CD140a, which is a long-known marker for murine
mesenchymal stromal cells (MSCs), was also reported on
human fetal bone marrow MSCs capable of supporting
HSPC expansion (Pinho et al., 2013). In contrast, later
studies using adult human bone marrow reported that
MSCs with hematopoiesis-supporting ability were highly
enriched within the CD140alo/ population but not in
CD140a+ cells (Li et al., 2014). These conflicting results
may be explained by reports of human mesenchymal
stroma, including our own (Corselli et al., 2013), which
suggest that CD140a expression is differentially regulated
both developmentally and across tissue types. A recent
report demonstrated that nestin+ mesenchyme in the
Figure 4. hPSC-Derived CD146hiCD73hi Mesenchyme Shares a Molecular Signature with Primary Human Adult Pericytes
(A and B) Gene set enrichment analysis of hPSC-derived mesenchyme and lipoaspirate-derived populations (both freshly sorted and
cultured). (A) Positive and (B) negative signatures were defined, respectively, as up- and downregulated genes in hPSC-derived
CD146hiCD73hi compared with hPSC-derived CD146loCD73lo cells. The x axis represents genes ranked from positive to negative fold change
in lipoaspirate-CD146+ compared with lipoaspirate-CD146 cells. Genes in the core enrichment set are highlighted (shaded gray boxes)
and selected genes in this core enrichment set are shown.
(C) Up- and downregulated genes common to the core sets of CD146hi from hPSC and fresh and cultured primary CD146+ cells were imported
into the STRING database, which identified a network of known protein-protein interactions (enrichment p value = 0), along with a number
of high-confidence (score > 0.9999) predicted interactions. Line thickness is proportional to the confidence level of each interaction.
See also Table S1.murine fetal liver HSC niche expressed CD146
(Khan et al., 2016), further supporting the inclusion of
CD146 in defining mesenchyme with HSC niche activity.
In the present study, both CD146hiCD73hi and
CD146loCD73lo cells from hPSCs expressed known HSC
niche genes, such as SLIT2 and ANGPT1. However, other
niche factors, such as KITL, JAG1, and IGFBP2, were specif-
ically upregulated in CD146hiCD73hi cells. As is likely for
the components of the hematopoietic niche in vivo, we
conclude the CD146hiCD73hi mesenchymal subset sup-
ports HSPCs through a combination of mechanisms that
involve cell-cell contact (e.g., Notch signaling and adhe-
sion molecules) and secreted factors (e.g., Wnt regulators
and cytokines). Time course analysis for the developmentof CD146hiCD73hi and CD146loCD73lo cells showed that
they could each be distinguished early during mesen-
chymal differentiation. However, clonal data are needed
to understand the developmental relationships of these
cell types. It should also be acknowledged that it remains
unclear whether the phenotypes examined in our
study represent cell types at the extremes of a functional
spectrum.
The identification of distinct mesenchymal subsets
generated from hPSCs provides a foundation from which
developmental and functional differences can be further
defined, and the application of each population for
cell therapy explored. The ability to prospectively
isolate human stroma with HSC-supporting capacity isStem Cell Reports j Vol. 10 j 436–446 j February 13, 2018 443
particularly relevant given clinical interest in using
stroma co-culture as a platform for HSC expansion (Hof-
meister et al., 2007).
While this study focused on defining cellular subsets
within hPSC-derived mesenchyme that would support a
well-characterized HSPC population, the existence of
distinct mesenchymal subsets during hPSC differentiation
has broader implication for the directed differentiation of
hPSCs toward definitive, functional HSCs. Further study
will be needed to define the optimal hPSC-derived mesen-
chyme that would promote HSC specification.EXPERIMENTAL PROCEDURES
Mesoderm Differentiation from hPSCs to Generate
hEMPs
The hPSC lines H1 (WiCell, Madison,WI), and UCLA3 and UCLA6
(UCLA BSCRC hESC Core) were maintained and expanded on
irradiated primary mouse embryonic fibroblasts (EMD Millipore,
Billerica, MA). All hPSC experiments were approved by the UCLA
Embryonic Stem Cell Research Oversight (ESCRO) committee.
Mesoderm commitment was induced as described previously
(Evseenko et al., 2010; Hoffman and Calvi, 2014) (Supplemental
Experimental Procedures). CD326CD56+ embryonic mesoderm
progenitors (hEMPs) were isolated by flow cytometry at day 3.5
(Figure 1A) and seeded onto Matrigel for mesenchymal differenti-
ation over the next 14 days.Mesenchymal Differentiation from hEMPs
To induce mesenchymal differentiation, hEMPs were seeded at
50,000 cells/well into 6-well tissue culture plates, pre-coated with
Matrigel. Day 0–7 of differentiation, MesenCult Proliferation Kit,
Human (STEMCELL Technologies) supplemented with SB-
431542 (10 mM, R&D Systems) was used. Day 0–3, 10 mM Rock in-
hibitor (Y27632 hydrochloride; R&D Systems) and 10 mg/mL
gentamicin (Gibco, Thermo Fisher Scientific, Waltham, MA) were
also added. Day 7–14, medium was switched to EGM-2 (Lonza)
supplemented with SB-431542 (10 mM). Day 14–18, cells were
dissociated into single-cell suspension with Accutase (Innovative
Cell Technologies, San Diego, CA), and analyzed or isolated by
fluorescence-activated cell sorting (FACS) (see Supplemental
Experimental Procedures).Co-culture of Stromal Cells and CB CD34+ Cells
hEMP-derivedmesenchyme (CD146hiCD73hi andCD146loCD73lo)
was isolated from mesenchymal cultures after 14–18 days and
re-plated in 96-well tissue culture-treated plates at 6.5 3 103 cells
per well in 100 mL of EGM-2. Three days later, CB CD34+ cells
(>80% purity, 1 3 105 per well) were plated on 80% confluent
stroma in 200 mL of co-culture medium consisting of RPMI 1640,
L-glutamine, 5% fetal bovine serum, and penicillin/streptavidin.
No supplemental cytokines were added unless otherwise indicated
(LinCD34+CD38 experiments).Cellswereharvestedafter2weeks
unless otherwise indicated for FACS analysis, CFU assay, and in vivo
repopulating assay.444 Stem Cell Reports j Vol. 10 j 436–446 j February 13, 2018Graphical and Statistical Analysis
Graphs were generated and statistics analyzed using GraphPad
Prism software. Paired parametric two-tailed t tests were used to
calculate p values except in cases where normalized values
were used, in which case unpaired parametric t tests were used.
p < 0.05 was considered statistically significant.
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